Home LiteratureArticle Details
PMID: 2936302 Published · ppublish English Journal Article Review

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Antimicrobial agents and chemotherapy ·Vol. 28 ·No. 5 ·1985-11-00 ·Pages 716-21

Hooper DC, Wolfson JS

Abstract

暂无摘要

MeSH Terms
Anti-Bacterial Agents/adverse effects,blood,pharmacology,therapeutic use Bacteria/drug effects Blood Proteins/metabolism Ciprofloxacin Enoxacin Fluorine/adverse effects,blood,pharmacology,therapeutic use Humans Kidney/metabolism Kinetics Naphthyridines/adverse effects,blood,pharmacology,therapeutic use Norfloxacin/adverse effects,analogs & derivatives,blood,pharmacology,therapeutic use Ofloxacin Oxazines/adverse effects,blood,pharmacology,therapeutic use Pefloxacin Protein Binding Quinolines/adverse effects,blood,pharmacology,therapeutic use Urinary Tract Infections/drug therapy
Chemicals
Anti-Bacterial Agents Blood Proteins Naphthyridines Oxazines Quinolines Fluorine Pefloxacin Enoxacin Ciprofloxacin Ofloxacin Norfloxacin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hooper D C
Wolfson J S
References (48)
48 references, click to expand
  1. The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin.
    J Antimicrob Chemother. 1984 May;13 Suppl B:85-8 PMID: 6234280
  2. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
    J Antimicrob Chemother. 1984 May;13 Suppl B:79-83 PMID: 6234279
  3. Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study.
    J Antimicrob Chemother. 1984 May;13 Suppl B:99-105 PMID: 6234282
  4. Enoxacin raises plasma theophylline concentrations.
    Lancet. 1984 Jul 14;2(8394):108-9 PMID: 6145999
  5. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.
    N Engl J Med. 1984 Jul 19;311(3):137-40 PMID: 6234465
  6. Quinolones and raised plasma concentrations of theophylline.
    Lancet. 1984 Sep 1;2(8401):530 PMID: 6147598
  7. Pharmacokinetics and tissue penetration of enoxacin.
    Antimicrob Agents Chemother. 1984 Jul;26(1):17-9 PMID: 6591851
  8. Pharmacokinetics of intravenously administered ciprofloxacin.
    Antimicrob Agents Chemother. 1984 Aug;26(2):208-10 PMID: 6486762
  9. Pharmacokinetic studies of norfloxacin in laboratory animals.
    Chemotherapy. 1984;30(5):288-96 PMID: 6237890
  10. Dose- and sex-independent disposition of ciprofloxacin.
    Eur J Clin Microbiol. 1984 Aug;3(4):363-6 PMID: 6489328
  11. Pharmacokinetics of norfloxacin in renal failure.
    J Antimicrob Chemother. 1984 Oct;14(4):439 PMID: 6238930
  12. The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.
    J Antimicrob Chemother. 1984 Sep;14 Suppl C:63-9 PMID: 6389476
  13. Pharmacokinetics and tolerance of enoxacin in healthy volunteers administered at a dosage of 400 mg twice daily for 14 days.
    J Antimicrob Chemother. 1984 Sep;14 Suppl C:71-4 PMID: 6389477
  14. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
    J Antimicrob Chemother. 1984 Sep;14 Suppl C:83-9 PMID: 6594325
  15. A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.
    J Antimicrob Chemother. 1984 Sep;14 Suppl C:91-4 PMID: 6438048
  16. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.
    J Pharm Sci. 1984 Oct;73(10):1379-82 PMID: 6594505
  17. Multiple-dose ciprofloxacin kinetics in normal subjects.
    Clin Pharmacol Ther. 1984 Sep;36(3):384-8 PMID: 6467798
  18. Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.
    Antimicrob Agents Chemother. 1984 Sep;26(3):289-91 PMID: 6594970
  19. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
    Antimicrob Agents Chemother. 1984 Oct;26(4):481-4 PMID: 6240223
  20. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
    Antimicrob Agents Chemother. 1984 Nov;26(5):741-4 PMID: 6517556
  21. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.
    Antimicrob Agents Chemother. 1984 Nov;26(5):757-61 PMID: 6517559
  22. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.
    J Antimicrob Chemother. 1984 Dec;14(6):641-5 PMID: 6440885
  23. The pharmacokinetics and tissue penetration of ofloxacin.
    J Antimicrob Chemother. 1984 Dec;14(6):647-52 PMID: 6596301
  24. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.
    Chemotherapy. 1985;31(1):13-8 PMID: 3156024
  25. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
    Antimicrob Agents Chemother. 1985 Mar;27(3):297-301 PMID: 3158272
  26. Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.
    Antimicrob Agents Chemother. 1985 Mar;27(3):350-2 PMID: 3158273
  27. Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine.
    Antimicrob Agents Chemother. 1985 Mar;27(3):353-6 PMID: 3158274
  28. Pharmacokinetics of ciprofloxacin after oral and parenteral administration.
    Antimicrob Agents Chemother. 1985 Mar;27(3):375-9 PMID: 3158275
  29. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
    Antimicrob Agents Chemother. 1985 Mar;27(3):422-3 PMID: 3158277
  30. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  31. Treatment of uncomplicated gonorrhea with rosoxacin.
    Antimicrob Agents Chemother. 1981 Nov;20(5):625-9 PMID: 6798924
  32. Urinary tract antiseptics.
    Med Clin North Am. 1982 Jan;66(1):199-208 PMID: 7038329
  33. Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.
    Antimicrob Agents Chemother. 1983 Jan;23(1):1-7 PMID: 6219615
  34. Norfloxacin disposition after sequentially increasing oral doses.
    Antimicrob Agents Chemother. 1983 Feb;23(2):284-8 PMID: 6220672
  35. Bactericidal intraprostatic concentrations of norfloxacin.
    Lancet. 1983 Jul 30;2(8344):280 PMID: 6135100
  36. Norfloxacin-induced rheumatic disease.
    N Z Med J. 1983 Jul 27;96(736):590 PMID: 6223241
  37. Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.
    Eur J Clin Microbiol. 1983 Jun;2(3):253-9 PMID: 6224683
  38. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
    Eur J Clin Microbiol. 1983 Jun;2(3):260-5 PMID: 6224684
  39. Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
    Eur J Clin Microbiol. 1983 Jun;2(3):266-9 PMID: 6224685
  40. Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
    J Antimicrob Chemother. 1983 Jun;11(6):589-92 PMID: 6224769
  41. Pharmacokinetics and tissue penetration of ciprofloxacin.
    Antimicrob Agents Chemother. 1983 Nov;24(5):784-6 PMID: 6660852
  42. Norfloxacin in acute urinary tract infections.
    Practitioner. 1984 Jan;228(1387):111-7 PMID: 6229726
  43. The pharmacokinetics and tissue penetration of norfloxacin.
    J Antimicrob Chemother. 1984 Jan;13(1):87-92 PMID: 6230344
  44. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
    J Antimicrob Chemother. 1984 Mar;13(3):237-44 PMID: 6586712
  45. Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.
    Antimicrob Agents Chemother. 1984 Apr;25(4):463-72 PMID: 6587830
  46. Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin.
    J Antimicrob Chemother. 1984 May;13 Suppl B:107-12 PMID: 6234270
  47. Norfloxacin--a review of pharmacology and tissue penetration.
    J Antimicrob Chemother. 1984 May;13 Suppl B:59-64 PMID: 6234277
  48. Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
    J Antimicrob Chemother. 1984 May;13 Suppl B:89-94 PMID: 6234281
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
DOI
10.1128/AAC.28.5.716
Published
1985-11-00
Pages
716-21
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC176369
Subset
IM
External Links
PubMed source DOI: 10.1128/AAC.28.5.716 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2